These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9149873)

  • 21. Dominant host range selection of vaccinia recombinants by rescue of an essential gene.
    Holzer GW; Gritschenberger W; Mayrhofer JA; Wieser V; Dorner F; Falkner FG
    Virology; 1998 Sep; 249(1):160-6. PubMed ID: 9740787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A PCR-based method for manipulation of the vaccinia virus genome that eliminates the need for cloning.
    Turner PC; Moyer RW
    Biotechniques; 1992 Nov; 13(5):764-71. PubMed ID: 1418979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient host range selection for genetic engineering of modified vaccinia virus Ankara.
    Staib C; Drexler I; Ohlmann M; Wintersperger S; Erfle V; Sutter G
    Biotechniques; 2000 Jun; 28(6):1137-42, 1144-6, 1148. PubMed ID: 10868279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Construction of recombinant vaccinia virus: cloning into the thymidine kinase locus.
    Byrd CM; Hruby DE
    Methods Mol Biol; 2004; 269():31-40. PubMed ID: 15114005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alternative genetic method to test essential vaccinia virus early genes.
    Kato SE; Greco FA; Damaso CR; Condit RC; Moussatché N
    J Virol Methods; 2004 Jan; 115(1):31-40. PubMed ID: 14656458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A vaccinia virus transfer vector using a GUS reporter gene inserted into the I4L locus.
    Howley PM; Spehner D; Drillien R
    Gene; 1996 Jun; 172(2):233-7. PubMed ID: 8682309
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of Recombinant Vaccinia Viruses.
    Wyatt LS; Earl PL; Moss B
    Curr Protoc Protein Sci; 2017 Aug; 89():5.13.1-5.13.18. PubMed ID: 28762491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plaque size phenotype as a selectable marker to generate vaccinia virus recombinants.
    Rodriguez JF; Esteban M
    J Virol; 1989 Feb; 63(2):997-1001. PubMed ID: 2911129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient dominant selection of recombinant vaccinia viruses.
    Falkner FG; Moss B
    J Virol; 1990 Jun; 64(6):3108-11. PubMed ID: 2159565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BiZyme: a novel fusion protein-mediating selection of vaccinia virus recombinants by fluorescence and antibiotic resistance.
    Hansen SG; Cope TA; Hruby DE
    Biotechniques; 2002 May; 32(5):1178, 1180, 1182-7. PubMed ID: 12019792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants.
    Franke CA; Rice CM; Strauss JH; Hruby DE
    Mol Cell Biol; 1985 Aug; 5(8):1918-24. PubMed ID: 3018537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effective method of introducing plasmid DNA into eukaryotic cells by using liposomes for producing vaccinia virus recombinants].
    Slepushkin VA; Bukrinskiĭ MI
    Biull Eksp Biol Med; 1987 Oct; 104(10):478-80. PubMed ID: 2823928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of recombinant vaccinia viruses using PUV-inactivated virus as a helper.
    Timiryasova TM; Chen B; Fodor N; Fodor I
    Biotechniques; 2001 Sep; 31(3):534, 536, 538-40. PubMed ID: 11570497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction of a novel set of transfer vectors to study vaccinia virus replication and foreign gene expression.
    Dvoracek B; Shors T
    Plasmid; 2003 Jan; 49(1):9-17. PubMed ID: 12583996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct identification of recombinant vaccinia virus plaques by PCR.
    Pasamontes L; Gubser J; Wittek R; Viljoen GJ
    J Virol Methods; 1991; 35(2):137-41. PubMed ID: 1816251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of feline immunodeficiency virus (FIV) gag gene in vaccinia virus vector.
    Wojcik J
    Acta Microbiol Pol; 1995; 44(2):191-6. PubMed ID: 8906935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombination-independent selectable cloning vectors.
    Merchlinsky M; Moss B
    Virology; 1992 Sep; 190(1):522-6. PubMed ID: 1529553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome.
    Cottingham MG; Gilbert SC
    J Virol Methods; 2010 Sep; 168(1-2):233-6. PubMed ID: 20417665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seven major genomic deletions of vaccinia virus Tiantan strain are sufficient to decrease pathogenicity.
    Li Y; Sheng Y; Chu Y; Ji H; Jiang S; Lan T; Li M; Chen S; Fan Y; Li W; Li X; Sun L; Jin N
    Antiviral Res; 2016 May; 129():1-12. PubMed ID: 26821204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of recombinant vaccinia viruses.
    Earl PL; Moss B; Wyatt LS; Carroll MW
    Curr Protoc Protein Sci; 2001 May; Chapter 5():Unit5.13. PubMed ID: 18429179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.